New Drug-resistant Strain of Salmonella is Identified

Article

Newswise -- Researchers from Taiwan report the identification of a new form of drug-resistant salmonella bacterium in this week's issue of The Lancet.

Salmonella enterica serotype choleraesuis usually causes infections that require antimicrobial treatment. Multidrug-resistant strains have been identified, but the antimicrobial ceftriaxone has been effective against them so far.

Professor J T Ou, from the Chang Gung University College of Medicine in Taoyuan, Taiwan, and colleagues isolated a strain of Salmonella enterica serotype choleraesuis that was resistant to all antimicrobials commonly used to treat salmonellosis, including ceftriaxone and ciprofloxacin. The bacterium came from a 58-year-old man with sepsis who subsequently died.

The drug resistance was due to changes in the genes of the bacteria, including some in a genetic element that can potentially be transmitted between bacteria. Although this strain was from only one patient, the public-health implications of multidrug-resistant salmonella are serious. "Constant surveillance is needed to prevent its further spread," warn the authors.

Source: The Lancet

Recent Videos
Damien Berg, BA, BS, CRCST, AAMIF, is the vice president of strategic initiatives for the HSPA.
Annet Adegboyega, DNP, MSN, BSN, RN, CNOR; Mihyun "Rose" Jang, MSN, MPH, BSN, RN, CNOR; and Renilda Tijones, MSN, BSN, RN, CNOR.
Roundtable of Vet IPs (Adobe Stock)
APIC 2025 President Carol McLay, DrPH, MPH, RN, CIC FAPIC   (Image credit: APIC)
Paulo J. M. Brois, DVM, MSN, RN; Luisa M. P. Soares, RN; and Teresa A. Santos, RN, at #AORN2025
Michael Sinnott, MBBS, FACEM, FRACP, at 2025 AORN Global Conference & Expo.
Roundtable of Vet IPs
Meet Marjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB.
A veterinarian in a protective suit takes tests on animals on a farm.   (Adobe Stock 829620654 by Яна Ерік Татевосян)
Related Content